Botulinum neurotoxin for treatment of disorders associated with melanocyte hyperactivity and/or excess melanin
US10912823B2 · kind B2 · utility
0Cited by
4References
20Claims
0Family size
Assignee
Inventors
Key dates
| Filing date | May 30, 2018 |
| Grant date | Feb 9, 2021 |
| Priority date | — |
| Expiry date | May 30, 2038 |
Classification
- Technology area (CPC A)Human Necessities
- CPC primaryA61K2800/91
- WIPO fieldPharmaceuticals
- WIPO sectorChemistry
Abstract
Methods for treating melanin-related afflictions of the skin, such as hyperpigmentation, are provided. The methods comprise administering a composition comprising BoNT/DC.
Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.